Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Braskem S.A.NYSE: BAK

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of R$1.17B fell 1.5% year over year, behind the +11.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.1% from the prior quarter. Over 3 fiscal years it compounded at -1.1% a year.

Context

  • Depreciation & amortization amounted to 6.6% of revenue in FY2025, up 1.8 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -1.5% toward the trailing-twelve-month pace of +11.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
R$1.17B+1.1% QoQ
Last fiscal yearDec 2025
R$4.58B+22.0% YoY
LTMMar 2026
R$5.14B+11.5% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.5%——
1 year+22.0%——
3-year CAGR-1.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

BRL · from the income statement

Latest · FY2025
4.58B BRL
Year-over-year change
+22.0%
4-year CAGR
+2.3%

Depreciation & Amortization vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +11.5% is the 7th highest of 11, against a peer median of +13.7%.
  • Depreciation & amortization amounts to 7.7% of revenue for BAK, versus a peer median of 10.4%.
BAK Competitors
Depreciation & Amortization for BAK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$5.14B BRL+11.5%-1.1%7.7%
RYAMRayonier Advanced Materials Inc.LTM Mar 2026$164.79M USD+21.9%-0.2%11.5%
SCLStepan CompanyLTM Mar 2026$129.77M USD+14.0%+10.0%5.5%
WLKPWestlake Chemical Partners LPLTM Mar 2026$106.17M USD+13.4%+1.9%8.6%
UANCVR Partners, LPLTM Mar 2026$83.79M USD-3.5%-0.1%13.0%
ECVTEcovyst Inc.LTM Mar 2026$75.96M USD-11.4%-0.2%9.3%
MUXMcEwen Mining Inc.LTM Mar 2026$30.26M USD+2.2%+16.5%12.8%
REXREX American Resources CorporationLTM Apr 2026$17.65M USD-15.3%-10.4%2.7%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$4.82M USD+831.9%+197.6%17.9%
CNLCollective Mining Ltd.LTM Mar 2026$1.01M USD+120.6%+56.2%—
NAKNorthern Dynasty Minerals Ltd.LTM Mar 2026CA$244.96K CAD+58.6%-12.8%—
Peer median (excluding BAK) —+13.7%+0.9%10.4%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue105.63B96.52B70.57B77.41B69.33B
Cost of Revenue73.57B85.16B67.55B71.41B67.8B
Gross Profit32.06B11.36B3.02B6B1.53B
Gross Margin30.3%11.8%4.3%7.7%2.2%
Research & Development297M374M383M463M450.96M
Selling, General & Admin4.58B4.87B4.39B4.63B4.68B
Operating Expenses4.88B5.25B4.77B4.99B5.48B
Depreciation & Amortization4.18B4.73B5.21B3.75B4.58B
EBITDA25.33B8.11B3.26B2.7B631.35M
EBITDA Margin24.0%8.4%4.6%3.5%0.9%
Operating Income27.18B6.11B(1.75B)1.01B(3.95B)
Operating Margin25.7%6.3%-2.5%1.3%-5.7%
Interest Income440M1.05B873M1.26B711.74M
Interest Expense3.19B3.33B4.78B5.44B5.82B
Other Income / Expenses(9.22B)(6.07B)(4.44B)(18.75B)1.16B
Income Before Tax17.96B47M(6.19B)(17.73B)(2.79B)
Pre-Tax Margin17.0%0.0%-8.8%-22.9%-4.0%
Income Tax Expense4B868M(1.3B)(5.68B)7.96B
Net Income13.99B(336M)(4.58B)(11.32B)(9.69B)
Net Margin13.2%-0.3%-6.5%-14.6%-14.0%
EPS (Basic)35.12(2.06)(11.50)(28.40)(24.32)
EPS (Diluted)35.08(2.06)(11.50)(28.40)(24.32)
Weighted Avg Shares398.11M398.24M398.35M398.6M398.6M
Weighted Avg Shares (Diluted)398.61M398.6M398.35M398.6M398.6M

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.